Vir(VIR) - 2024 Q2 - Earnings Call Transcript

Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Richard Lepke - Senior Director, Investor Relations Marianne De Backer - Chief Executive Officer Jennifer Towne - Executive Vice President and Chief Scientific Officer Mark Eisner - Executive Vice President and Chief Medical Officer Brent Sabatini - Chief Accounting Officer Conference Call Participants Phil Nadeau - TD Cowen Nikola Gasic - Leerink Paul Choi - Goldman Sachs Eric Joseph - J.P. ...